BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6177439)

  • 41. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of functional and morphological differentiation of cultured mouse myeloid leukemia cells by tumor promoters.
    Kasukabe T; Honma Y; Hozumi M
    Gan; 1979 Feb; 70(1):119-23. PubMed ID: 286666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A keratin of fetal skin is reexpressed in human keratinocytes transformed by SV40 virus or treated with the tumor promoter TPA.
    Darmon M; Delescluse C; Semat A; Bernard B; Bailly J; Prunieras M
    Exp Cell Res; 1984 Sep; 154(1):315-9. PubMed ID: 6205890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Induction of baboon herpes virus antigens in producing lymphoblastoid cells].
    D'iachenko AG; Onishchuk FD
    Eksp Onkol; 1984; 6(5):46-9. PubMed ID: 6210192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.
    Fibach E; Yamasaki H; Weinstein IB; Marks PA; Rifkind RA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3685-8. PubMed ID: 279396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth stimulation of microenvironment-dependent mouse leukemias by tumor-promoting phorbol esters.
    Hiai H; Nishizuka Y
    J Natl Cancer Inst; 1981 Dec; 67(6):1333-40. PubMed ID: 6975850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
    Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
    Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
    J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TPA-resistance in Friend erythroleukemia cells: role of membrane lipid fluidity.
    Fisher PB; Cogan U; Horowitz AD; Schachter D; Weinstein IB
    Biochem Biophys Res Commun; 1981 May; 100(1):370-6. PubMed ID: 6942838
    [No Abstract]   [Full Text] [Related]  

  • 51. The toxic response of preneoplastic rat tracheal epithelial cells to 12-O-tetradecanoylphorbol-13-acetate.
    Nettesheim P; Gray T; Barrett JC
    Carcinogenesis; 1985 Oct; 6(10):1427-34. PubMed ID: 4042272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoting effect of 12-O-tetradecanoylphorbol-13-acetate on the in vitro malignant transformation of fetal rat brain cells exposed in utero to ethylnitrosourea.
    Kokunai T; Korosue K; Tamaki N; Matsumoto S
    Cancer Res; 1986 Mar; 46(3):1377-81. PubMed ID: 3753661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strain difference in immune response of the rat to NRK cells infected with spleen focus-forming virus of the Friend leukaemia virus complex.
    Kai K; Yoshida M; Odaka T
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2169-76. PubMed ID: 6413646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ornithine decarboxylase activity and DNA synthesis after treatment of cells in culture with 12-O-tetradecanoylphorbol-13-acetate.
    O'Brien TG; Lewis MA; Diamond L
    Cancer Res; 1979 Nov; 39(11):4477-80. PubMed ID: 498078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Enhancement of the transforming activity of simian adenovirus S5 and of the DNA from human adenovirus type I by benzo(a)pyrene and TPA].
    Potebnia GP; Struk VI; Naroditskiĭ BS; Ponomarev TI; Tikhonenko TI
    Eksp Onkol; 1986; 8(2):26-9. PubMed ID: 3698879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of human T lymphocyte colony formation by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kitamura K; Urabe A; Ozawa K; Kimura Y; Takaku F
    Exp Hematol; 1983 Nov; 11(10):1014-20. PubMed ID: 6607173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 12-O-tetradecanoylphorbol-13-acetate (TPA)-nonproliferative variant of 3T3 cells is resistant to TPA-enhanced gene amplification.
    Herschman HR
    Mol Cell Biol; 1985 May; 5(5):1130-5. PubMed ID: 4000120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells.
    Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F
    Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects.
    Giroldi L; Hollstein M; Yamasaki H
    Carcinogenesis; 1988 May; 9(5):817-21. PubMed ID: 3163274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.